News
As new therapies for obesity enter the market, biopharmaceutical companies will need to tune commercial strategies to win ...
On this weeks Business of Biotech episode, Ebrahim Delpassand, M.D., founder, CEO, and chairman of the board at RadioMedix talks about his personal journey standing up and growing a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback